{"id":68790,"date":"2026-02-22T07:34:38","date_gmt":"2026-02-22T07:34:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68790"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"bpc-157-tb-500-blend","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/bpc-157-tb-500-blend\/","title":{"rendered":"BPC-157 + TB-500 \u30d6\u30ec\u30f3\u30c9"},"content":{"rendered":"<p><!-- medsbase-related-alts-v1 --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 16px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 17px;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 BPC-157 + TB-500 \u30d6\u30ec\u30f3\u30c9\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\">This is a pre-mixed peptide supplied as a 50\/50 blend of BPC-157 and TB-500 (Thymosin Beta-4) in a single lyophilized vial. Three total-mg strengths are available: <strong>10 mg<\/strong> \uff08BPC 5 mg + TB 5 mg\uff09, <strong>20 mg<\/strong> \uff0810 mg + 10 mg\uff09\u3001\u304a\u3088\u3073 <strong>30 mg<\/strong> (15 mg + 15 mg) \u2014 each in pack sizes of 10, 20, or 30 vials. The pre-blend saves a reconstitution step for protocols that study these two compounds together.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<h2>BPC-157 + TB-500 Blend \u2014 Pre-Mixed Dual-Peptide Compound<\/h2>\n<p>BPC-157 and TB-500 are the two most-studied peptides in the tissue-repair and systemic-recovery space. They target complementary pathways: BPC-157 (Body Protection Compound, a 15-amino-acid fragment derived from a gastric protein) is investigated for localized tissue repair, angiogenesis, and modulation of growth factors, while TB-500 (a synthetic fragment of Thymosin Beta-4) is studied for systemic cell migration, G-actin sequestration, and broader recovery signaling. Study protocols that investigate the two compounds together typically dose them in a 1:1 ratio, which is why a pre-mixed 50\/50 blend has become a standard supply format. This product eliminates the extra reconstitution step that would otherwise be required when running a combined-dosing study. <\/p>\n<h2>2\u3064\u306e\u5225\u3005\u306e\u30d0\u30a4\u30a2\u30eb\u3067\u306f\u306a\u304f\u3001\u30d6\u30ec\u30f3\u30c9\u3092\u4f7f\u7528\u3059\u308b\u7406\u7531\u306f\uff1f<\/h2>\n<p>Study labs running combined BPC-157 + TB-500 protocols have two supply choices: (a) order the peptides separately and reconstitute each vial independently, mixing the final doses at injection time, or (b) order a pre-blended vial and reconstitute once. Both approaches are valid. The blend is chosen most often when:<\/p>\n<ul>\n<li>The protocol is fixed at a 1:1 BPC:TB ratio across all study arms.<\/li>\n<li>\u518d\u69cb\u6210\u6642\u9593\u3001\u7121\u83cc\u64cd\u4f5c\u306e\u8ca0\u62c5\u3001\u304a\u3088\u3073\u30d0\u30a4\u30a2\u30eb\u306e\u5728\u5eab\u7ba1\u7406\u304c\u91cd\u8981\u306a\u30b3\u30b9\u30c8\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u308b\u5834\u5408\u3002<\/li>\n<li>\u30d0\u30c3\u30c1\u9593\u306e\u4e00\u5b9a\u6bd4\u7387\u304c\u6c42\u3081\u3089\u308c\u308b\u5834\u5408\uff08\u4e8b\u524d\u6df7\u5408\u54c1\u306f\u5358\u4e00\u306e\u4ed5\u69d8\u3067\u88fd\u9020\u3055\u308c\u307e\u3059\u304c\u3001\u5225\u3005\u306b\u6ce8\u6587\u3057\u305f\u30d0\u30a4\u30a2\u30eb\u306f\u7570\u306a\u308b\u88fd\u9020\u30ed\u30c3\u30c8\u304b\u3089\u4f9b\u7d66\u3055\u308c\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\uff09\u3002<\/li>\n<\/ul>\n<p>\u500b\u5225\u306e\u5316\u5408\u7269\u306f\u3001BPC-157\u3068TB-500\u306e\u72ec\u7acb\u3057\u305f\u7528\u91cf\u8abf\u6574\u304c\u5fc5\u8981\u306a\u30d7\u30ed\u30c8\u30b3\u30eb\u306e\u305f\u3081\u306b\u5f15\u304d\u7d9a\u304d\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u500b\u3005\u306e\u30da\u30d7\u30c1\u30c9\u306e\u80cc\u666f\u60c5\u5831\u306b\u3064\u3044\u3066\u306f\u3001\u5f53\u30b5\u30a4\u30c8\u306e <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> KYC\uff08Know Your Customer\uff09 <a href=\"https:\/\/medsbase.com\/ja\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf4\uff09\u30ac\u30a4\u30c9<\/a>. \u3002\u76f4\u63a5\u306e\u6bd4\u8f03\u6cbb\u7642\u306b\u3064\u3044\u3066\u306f\u3001 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500\u6bd4\u8f03<\/a>. <\/p>\n<h2>\u5f37\u5ea6\u30aa\u30d7\u30b7\u30e7\u30f3 \u2014 \u9078\u3073\u65b9<\/h2>\n<p>All three strengths contain the same 1:1 BPC-157: TB-500 ratio. The total-mg figure refers to the combined peptide mass per vial:<\/p>\n<ul>\n<li><strong>10 mg \u7dcf\u91cf<\/strong> \u2014 5 mg BPC-157 + 5 mg TB-500 per vial. Suited to protocols studying lower dose ranges or short study durations. Best cost per vial; highest per-mg cost.<\/li>\n<li><strong>20 mg \u7dcf\u91cf<\/strong> \u2014 10 mg BPC-157 + 10 mg TB-500 per vial. The most commonly ordered strength for multi-week protocols. Balanced on cost-per-mg and practical working-dilution volumes.<\/li>\n<li><strong>30 mg \u7dcf\u91cf<\/strong> \u2014 15 mg BPC-157 + 15 mg TB-500 per vial. Best cost per mg; suited to longer studies or higher-dose arms.<\/li>\n<\/ul>\n<p>10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb\u5165\u308a\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u304c\u6bb5\u968e\u7684\u306a\u4fa1\u683c\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u300220\u30d0\u30a4\u30a2\u30eb\u304a\u3088\u307330\u30d0\u30a4\u30a2\u30eb\u30d1\u30c3\u30af\u306f\u300110\u30d0\u30a4\u30a2\u30eb\u306e\u30a8\u30f3\u30c8\u30ea\u30fc\u30b5\u30a4\u30ba\u3068\u6bd4\u8f03\u3057\u3066\u3001\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a\u306e\u5927\u5e45\u306a\u7bc0\u7d04\u306b\u306a\u308a\u307e\u3059\u3002 <\/p>\n<h2>Reconstitution \u2014 Standard Protocol<\/h2>\n<p>\u30d6\u30ec\u30f3\u30c9\u306f\u51cd\u7d50\u4e7e\u71e5\u54c1\u3068\u3057\u3066\u4f9b\u7d66\u3055\u308c\u307e\u3059\u3002\u4f7f\u7528\u5e0c\u91c8\u65b9\u6cd5\u306f\u5358\u4e00\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u3068\u540c\u69d8\u3067\u3059\u3002<\/p>\n<ol>\n<li>\u9759\u83cc\u6c34\u3067\u6eb6\u89e3\u3057\u307e\u3059\u300220 mg\u30d0\u30a4\u30a2\u30eb\u306e\u4e00\u822c\u7684\u306a\u4f7f\u7528\u5e0c\u91c8\u6db2\u306f2 mL\u306e <a href=\"https:\/\/medsbase.com\/ja\/bac-water\/\">BAC Water<\/a>, \u3001\u7dcf\u30da\u30d7\u30c1\u30c9\u6fc3\u5ea610 mg\/mL\uff08BPC 5 mg\/mL + TB 5 mg\/mL\uff09\u3068\u306a\u308a\u307e\u3059\u3002<\/li>\n<li>BAC\u6c34\u3092\u30d0\u30a4\u30a2\u30eb\u306e\u5185\u58c1\u306b\u6cbf\u3063\u3066\u9759\u304b\u306b\u52a0\u3048\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u5674\u5c04\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u306730\uff5e60\u79d2\u9593\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u307e\u3059\u3002\u6fc0\u3057\u304f\u632f\u3089\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u7a7a\u6c17\u3068\u6c34\u306e\u754c\u9762\u3067\u306e\u652a\u62cc\u306f\u30da\u30d7\u30c1\u30c9\u69cb\u9020\u3092\u65ad\u7247\u5316\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/li>\n<li>\u6eb6\u89e3\u65e5\u3092\u30d0\u30a4\u30a2\u30eb\u306b\u30e9\u30d9\u30eb\u4ed8\u3051\u3057\u307e\u3059\u30022\uff5e8 \u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n<\/ol>\n<p>\u5e0c\u91c8\u8a08\u7b97\u3068\u3088\u304f\u3042\u308b\u6eb6\u89e3\u30a8\u30e9\u30fc\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001\u5f53\u793e\u306e <a href=\"https:\/\/medsbase.com\/ja\/bac-water-reconstitution-guide\/\">BAC\u6c34\u6eb6\u89e3\u30ac\u30a4\u30c9<\/a>. <\/p>\n<h2>Context \u2014 Combined BPC + TB Dosing<\/h2>\n<p>The rationale for studying BPC-157 and TB-500 together rests on their non-overlapping mechanisms. BPC-157 studies focuses on localized repair \u2014 angiogenesis, growth-factor modulation (FGF, VEGF, EGF), and tendon-to-bone attachment signaling. TB-500 studies targets systemic cell migration, G-actin binding, and broader inflammation-resolution pathways. In combination protocols, investigators hypothesize additive or even synergistic effects across the overlap zone between localized and systemic recovery. Typical reported protocol dose ranges (per peptide component):<\/p>\n<ul>\n<li>BPC-157\u6210\u5206\uff1a1\u56de250\uff5e500 \u00b5g\u30011\u65e51\uff5e2\u56de\u30014\uff5e8\u9031\u9593\u306e\u30b5\u30a4\u30af\u30eb\u3067\u3002<\/li>\n<li>TB-500\u6210\u5206\uff1a\u90312\uff5e5 mg\u3001\u901a\u5e38\u306f\u90312\uff5e3\u56de\u306b\u5206\u5272\u6295\u4e0e\u3002<\/li>\n<\/ul>\n<p>These figures reflect published studies protocols and are not prescribing recommendations. Neither BPC-157 nor TB-500 is approved for human therapeutic use by the FDA, EMA, MHRA, or TGA. Both are supplied as compounds for clinical investigation only. <\/p>\n<h2>\u4fdd\u7ba1\u304a\u3088\u3073\u53d6\u308a\u6271\u3044\u306b\u3064\u3044\u3066<\/h2>\n<ul>\n<li>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f2\uff5e8 \u00b0C\uff08\u51b7\u8535\u5eab\uff09\u3067\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u77ed\u6642\u9593\u306e\u5ba4\u6e29\u8f38\u9001\u306f\u8a31\u5bb9\u3055\u308c\u307e\u3059\u3002<\/li>\n<li>\u6eb6\u89e3\u5f8c\u306f\u6eb6\u6db2\u3092\u51b7\u8535\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u51cd\u7d50\u878d\u89e3\u306e\u7e70\u308a\u8fd4\u3057\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n<li>\u76f4\u5c04\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u9577\u671f\u51b7\u8535\u4fdd\u5b58\u306b\u306f\u3001\u30a2\u30f3\u30d0\u30fc\u30d0\u30a4\u30a2\u30eb\u307e\u305f\u306f\u30a2\u30eb\u30df\u30db\u30a4\u30eb\u5305\u88c5\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002<\/li>\n<li>\u6bce\u56de\u306e\u91dd\u523a\u3057\u524d\u306b\u300170%\u30a4\u30bd\u30d7\u30ed\u30d4\u30eb\u30a2\u30eb\u30b3\u30fc\u30eb\u3067\u30b4\u30e0\u6813\u3092\u6d88\u6bd2\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/li>\n<\/ul>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u8907\u5408\u4f53\uff08BPC-157 137525-51-0\uff0fTB-500 77591-33-4\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub> \u00b7 TB-500: C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: 1419.55 Da \u00b7 TB-500: ~4963 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157\uff0815\u30a2\u30df\u30ce\u9178\uff09\uff0b\u30a2\u30bb\u30c1\u30eb\u5316\u30b5\u30a4\u30e2\u30b7\u30f3\u03b2-4\uff0843\u30a2\u30df\u30ce\u9178\uff09\u306e1\u30d0\u30a4\u30a2\u30eb\u5171\u51cd\u7d50\u4e7e\u71e5\u54c1<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u6df7\u5408\u7269\uff1a\u4f7f\u7528\u4e2d\u306e\u30b9\u30c8\u30c3\u30af\u306f2\uff5e8\u2103\uff08\u51b7\u8535\u5eab\uff09\u3001\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306f\u221220\u2103\u3067\u3002\u518d\u6eb6\u89e3\u6db2\uff1a2\uff5e8\u2103\u3067\u3001\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u6fc0\u3057\u3044\u632f\u3068\u3046\u3092\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u884c\u308f\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Related Compounds<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> \u2014 \u500b\u3005\u306e\u5316\u5408\u7269\u3002<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf4\uff09\u30ac\u30a4\u30c9<\/a> \u2014 \u500b\u3005\u306e\u5316\u5408\u7269\u3002<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500\u6bd4\u8f03<\/a> \u2014 2\u3064\u306e\u30da\u30d7\u30c1\u30c9\u306e\u76f4\u63a5\u6bd4\u8f03\u8a66\u9a13\u3002<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/ghk-cu-copper-peptide-anti-aging-guide\/\">GHK-Cu (Copper Peptide) guide<\/a> \u2014 BPC\/TB\u30d7\u30ed\u30c8\u30b3\u30eb\u3068\u6700\u3082\u983b\u7e41\u306b\u4f75\u7528\u3055\u308c\u308b\u56de\u5fa9\u5316\u5408\u7269\u3002<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/best-peptides-for-muscle-recovery\/\">\u7b4b\u8089\u56de\u5fa9\u30b9\u30bf\u30c3\u30af\u306b\u6700\u9069\u306a\u30da\u30d7\u30c1\u30c9<\/a> \u2014 \u4f75\u7528\u30d7\u30ed\u30c8\u30b3\u30eb\u3092\u7db2\u7f85\u3057\u305f\u30af\u30e9\u30b9\u30bf\u30fc\u30cf\u30d6\u8a18\u4e8b\u3002<\/li>\n<\/ul>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is the BPC-157: TB-500 ratio in the blend?<\/h3>\n<p>3\u3064\u306e\u5bb9\u91cf\u3059\u3079\u3066\u304c\u8cea\u91cf\u6bd41:1\u306e\u56fa\u5b9a\u6bd4\u7387\u3067\u4f9b\u7d66\u3055\u308c\u307e\u3059\u300210 mg\u30d0\u30a4\u30a2\u30eb\u306b\u306fBPC-157 5 mg + TB-500 5 mg\u304c\u542b\u307e\u308c\u300120 mg\u30d0\u30a4\u30a2\u30eb\u306b\u306f10 mg + 10 mg\u300130 mg\u30d0\u30a4\u30a2\u30eb\u306b\u306f15 mg + 15 mg\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002 <\/p>\n<h3>\u306a\u305c2\u3064\u306e\u5225\u3005\u306e\u30d0\u30a4\u30a2\u30eb\u3067\u306f\u306a\u304f\u3001\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u3092\u9078\u3076\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u306f\u518d\u69cb\u6210\u306e\u624b\u9593\u3092\u7701\u304d\u3001\u7814\u7a76\u5168\u4f53\u3092\u901a\u3058\u3066\u4e00\u8cab\u3057\u305f1:1\u306e\u6bd4\u7387\u3092\u4fdd\u8a3c\u3057\u307e\u3059\u3002\u5225\u3005\u306b\u6ce8\u6587\u3057\u305f\u30d0\u30a4\u30a2\u30eb\u306f\u30012\u3064\u306e\u5316\u5408\u7269\u3092\u72ec\u7acb\u3057\u3066\u7528\u91cf\u8abf\u7bc0\u3057\u305f\u3044\u5834\u5408\u306b\u3001\u3088\u308a\u67d4\u8edf\u6027\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002 <\/p>\n<h3>\u3069\u306e\u5bb9\u91cf\u3092\u6ce8\u6587\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>The 20 mg vial is the most commonly ordered strength for typical protocols. The 10 mg strength suits short studies or lower-dose arms. The 30 mg strength offers the best per-mg cost for longer studies or higher-dose arms. <\/p>\n<h3>\u30d6\u30ec\u30f3\u30c9\u306f\u3069\u306e\u3088\u3046\u306b\u6eb6\u89e3\u3057\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u9759\u83cc\u6c34\uff08BAC Water\uff09\u3092\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u300220 mg\u30d0\u30a4\u30a2\u30eb\u3067\u306f\u3001BAC Water 2 mL\u3092\u52a0\u3048\u308b\u3068\u3001\u7dcf\u30da\u30d7\u30c1\u30c9\u6fc3\u5ea610 mg\/mL\u306e\u4f7f\u7528\u6db2\u304c\u8abf\u88fd\u3067\u304d\u307e\u3059\u3002\u6c34\u306f\u30d0\u30a4\u30a2\u30eb\u306e\u58c1\u9762\u306b\u6cbf\u3063\u3066\u9759\u304b\u306b\u52a0\u3048\u3001\u3086\u3063\u304f\u308a\u3068\u56de\u3057\u3066\u6df7\u305c\u3066\u304f\u3060\u3055\u3044\u3002 \u2014 \u6c7a\u3057\u3066\u6fc0\u3057\u304f\u632f\u3089\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>\u6eb6\u89e3\u5f8c\u306e\u30d6\u30ec\u30f3\u30c9\u306e\u6709\u52b9\u671f\u9593\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u300130\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u7e70\u308a\u8fd4\u3057\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u6eb6\u6db2\u304c\u6fc1\u3063\u305f\u308a\u5909\u8272\u3057\u305f\u5834\u5408\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>What are the typical doses for this blend?<\/h3>\n<p>Published studies protocols typically dose 250\u2013500 \u00b5g of the BPC-157 component once or twice daily, and 2\u20135 mg of the TB-500 component weekly split across 2\u20133 doses. Because the ratio is fixed at 1:1, drawing a volume that delivers the target BPC-157 dose will simultaneously deliver the same mass of TB-500. <\/p>\n<h3>\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u306fFDA\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. Neither BPC-157 nor TB-500 is approved by the FDA, EMA, MHRA, TGA, or any other regulatory authority for human therapeutic use. This product is supplied strictly as a compound for clinical investigation. <\/p>\n<h3>\u30d6\u30ec\u30f3\u30c9\u306f\u5ba4\u6e29\u3067\u4fdd\u7ba1\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u672a\u6eb6\u89e3\u306e\u51cd\u7d50\u4e7e\u71e5\u54c1\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u77ed\u6642\u9593\u306e\u5ba4\u6e29\u4e0b\u306e\u8f38\u9001\u4e2d\u306f\u5b89\u5b9a\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u5230\u7740\u5f8c\u306f\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u4e00\u5ea6\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u5fc5\u305a\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>20 mg\u30d1\u30c3\u30af\u306f\u300110 mg\u30d1\u30c3\u30af2\u500b\u5206\u3088\u308a\u3082\u9577\u6301\u3061\u3057\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u30d0\u30a4\u30a2\u30eb\u5358\u4f4d\u3067\u306f\u3001\u306f\u3044 \u2014 20 mg\u30d0\u30a4\u30a2\u30eb\u306b\u306f\u30011\u30d0\u30a4\u30a2\u30eb\u3042\u305f\u308a10 mg\u30d0\u30a4\u30a2\u30eb\u306e2\u500d\u306e\u30da\u30d7\u30c1\u30c9\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u30ad\u30c3\u30c8\u5358\u4f4d\u3067\u306f\u300120 mg\u5f37\u5ea6\u306e10\u30d0\u30a4\u30a2\u30eb\u30d1\u30c3\u30af\u306b\u306f\u300110 mg\u5f37\u5ea6\u306e10\u30d0\u30a4\u30a2\u30eb\u30d1\u30c3\u30af2\u500b\u5206\u3068\u540c\u91cf\u306e\u7dcf\u30da\u30d7\u30c1\u30c9\uff08200 mg\uff09\u304c\u542b\u307e\u308c\u307e\u3059\uff08\u3053\u308c\u3082200 mg\uff09\u304c\u30011 mg\u3042\u305f\u308a\u306e\u30b3\u30b9\u30c8\u306f\u4f4e\u304f\u306a\u308a\u307e\u3059\u3002 <\/p>\n<h3>\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u6709\u52b9\u671f\u9650\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>2\uff5e8\u00b0C\u3067\u9069\u5207\u306b\u4fdd\u7ba1\u3055\u308c\u305f\u51cd\u7d50\u4e7e\u71e5\u30da\u30d7\u30c1\u30c9\u306f\u3001\u88fd\u9020\u5143\u304c\u8868\u793a\u3059\u308b\u6709\u52b9\u671f\u9650\u307e\u3067\u5b89\u5b9a\u3057\u3066\u3044\u307e\u3059 \u2014 \u901a\u5e38\u3001\u88fd\u9020\u304b\u308918\uff5e24\u304b\u6708\u3067\u3059\u3002\u5404\u30d0\u30a4\u30a2\u30eb\u306e\u6709\u52b9\u671f\u9650\u3092\u5fc5\u305a\u3054\u78ba\u8a8d\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u306f\u3001BPC-157\u3068TB-500\u3092\u5225\u3005\u306b\u6ce8\u6587\u3057\u305f\u5834\u5408\u3068\u6bd4\u3079\u3066\u3069\u306e\u3088\u3046\u306a\u9055\u3044\u304c\u3042\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u30d7\u30ed\u30c8\u30b3\u30eb\u304c1:1\u306e\u6bd4\u7387\u3067\u5b9f\u65bd\u3055\u308c\u308b\u5834\u5408\u3001\u6a5f\u80fd\u7684\u306b\u540c\u7b49\u3067\u3059\u3002\u30d6\u30ec\u30f3\u30c9\u306f\u30d0\u30c3\u30c1\u3054\u3068\u306b1\u56de\u306e\u518d\u69cb\u6210\u30b9\u30c6\u30c3\u30d7\u3092\u7701\u304d\u3001\u6bd4\u7387\u306e\u4e00\u8cab\u6027\u3092\u4fdd\u8a3c\u3057\u307e\u3059\u3002\u7814\u7a76\u7fa4\u9593\u30672\u3064\u306e\u30da\u30d7\u30c1\u30c9\u306e\u7528\u91cf\u3092\u72ec\u7acb\u3057\u3066\u5909\u3048\u305f\u3044\u5834\u5408\u306f\u3001\u5225\u3005\u306e\u30d0\u30a4\u30a2\u30eb\u3092\u4f7f\u7528\u3059\u308b\u65b9\u6cd5\u304c\u63a8\u5968\u3055\u308c\u307e\u3059\u3002 <\/p>\n<h3>\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u306f\u56fd\u969b\u914d\u9001\u3055\u308c\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002\u30da\u30d7\u30c1\u30c9\u306e\u307f\u306e\u3054\u6ce8\u6587\u306f\u3001\u5c02\u7528\u306e\u30da\u30d7\u30c1\u30c9\u5b85\u914d\u4fbf\u3067\u8ffd\u52a0\u6599\u91d1\u306a\u3057\u3067\u5168\u4e16\u754c\u306b\u914d\u9001\u3055\u308c\u307e\u3059\u3002\u30da\u30d7\u30c1\u30c9\u3068\u4ed6\u306e\u533b\u85ac\u54c1\u304c\u6df7\u5728\u3059\u308b\u3054\u6ce8\u6587\u306f\u3001\u6a19\u6e96\u306e\u56fd\u969b\u8ffd\u8de1\u914d\u9001\u3092\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002 <\/p>\n<h3>What is the recommended protocol for the BPC-157 + TB-500 blend?<\/h3>\n<p>Published preclinical studies using BPC-157 and TB-500 together employs each peptide at its individual protocol parameters \u2014 BPC-157 in the 250\u2013500 mcg range and TB-500 in the 2\u20135 mg range, with BPC-157 dosed more frequently due to its shorter half-life. Specific dosing for any application should be derived from peer-reviewed literature relevant to the study model. <\/p>\n<h3>Why does combining BPC-157 and TB-500 interest users?<\/h3>\n<p>BPC-157 and TB-500 target complementary tissue-repair pathways \u2014 BPC-157 primarily via VEGF, nitric oxide, and growth-hormone-receptor signalling with strong localised effects; TB-500 via actin binding, angiogenesis, and systemic distribution. Preclinical combination models have used both peptides together, and the two are frequently studied in the same repair and recovery contexts. <\/p>\n<h3>MedsBase\u306f\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u3092\u3069\u306e\u7d14\u5ea6\u57fa\u6e96\u3067\u4f9b\u7d66\u3057\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u304c\u5728\u5eab\u3059\u308b\u3053\u306e\u30d6\u30ec\u30f3\u30c9\u306e\u5168\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u51cd\u7d50\u4e7e\u71e5\u5f62\u614b\u306799%\u4ee5\u4e0a\u306eHPLC\u7d14\u5ea6\u3067\u4f9b\u7d66\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5206\u6790\u8a3c\u660e\u66f8\uff08COA\uff09\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5165\u624b\u53ef\u80fd\u3067\u3059 \u2014 \u3054\u6ce8\u6587\u5f8c\u3001\u30b5\u30dd\u30fc\u30c8\u30c1\u30fc\u30e0\u306b\u30e1\u30c3\u30bb\u30fc\u30b8\u3092\u304a\u9001\u308a\u3044\u305f\u3060\u3051\u308c\u3070\u3001\u304a\u53d7\u3051\u53d6\u308a\u306b\u306a\u3063\u305f\u30d0\u30a4\u30a2\u30eb\u306e\u30d0\u30c3\u30c1\u56fa\u6709\u306eCOA\u3092\u304a\u9001\u308a\u3057\u307e\u3059\u3002 <!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\"><strong>BPC-157 vs TB-500 \u2014 \u76f4\u63a5\u6bd4\u8f03\u3068\u4f75\u7528\u30d7\u30ed\u30c8\u30b3\u30eb\u30ac\u30a4\u30c0\u30f3\u30b9<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- medsbase-peptide-cluster-footer --><\/p>\n<div style=\"background: #eef7ee; border-left: 4px solid #4caf50; padding: 16px 22px; margin: 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 16px;\">Related Peptide Guides<\/h3>\n<ul style=\"margin: 8px 0 0 0;\">\n<li><a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 (Thymosin Beta-4) Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 \u2014 \u76f4\u63a5\u6bd4\u8f03<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/best-peptides-for-muscle-recovery\/\">\u7b4b\u8089\u56de\u5fa9\u306b\u6700\u9069\u306a\u30da\u30d7\u30c1\u30c9 \u2014 \u30b9\u30bf\u30c3\u30af\u30ac\u30a4\u30c9<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">All Peptides at MedsBase<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!-- \/medsbase-peptide-cluster-footer --><br \/>\n<!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u7d30\u80de\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u7d44\u7e54\u30e2\u30c7\u30ea\u30f3\u30b0\u3092\u4fc3\u9032<br \/>\n\u2705 Enhances angiogenic activity<br data-is-only-node=\"\" \/>\u2705 \u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u304c\u89b3\u5bdf<br \/>\n\u2705 \u5b9f\u9a13\u7684\u30a2\u30c3\u30bb\u30a4\u3067\u5b89\u5b9a<\/p>\n<p><strong>BPC-157 + TB-500<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70988,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5448,5441,5442],"class_list":["post-68790","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-bpc-157-tb-500-blend","product_tag-peptide","product_tag-tb-500","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/68790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=68790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70988"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=68790"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=68790"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=68790"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=68790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}